Examiner: KLINKEL, KORTNEY L

Tech Center 3600 • Art Units: 1600 1611 1615 1625 1627 1699 3649

This examiner grants 39% of resolved cases

Performance Statistics

39.4%

Allow Rate

-12.6% vs TC avg

602

Total Applications

+44.6%

Interview Lift

1427

Avg Prosecution Days

Based on 592 resolved cases, 2023–2026

2.9%

§101 Eligibility

16.0%

§102 Novelty

36.0%

§103 Obviousness

25.6%

§112 Clarity

App #	Title	Status	Assignee
18488191	COMPOUND FOR THE TREATMENT OF CANCER	Non-Final OA	Pfizer Inc.
18017421	SALT AND CRYSTAL FORM OF DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATE	Final Rejection	NANJING CHIA TAI TIANQING PHARMACEUTICAL CO., LTD.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.